United Drug plans to expand
Chief executive Liam FitzGerald said the company had a strong balance sheet after reporting a 7% increase in pre-tax profits for the six months to the end of March, to €35m. Operating profits also rose by 7% to €39.5m.
“The first half of 2012 has seen us advance our international healthcare services offering and return to good growth in profits and earnings while continuing to invest in our physical and IT infrastructure and management talent,” Mr FitzGerald said.





